Quadrant Capital Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-353
Closed -$38.7K 2648
2026
Q1
$38.7K Buy
353
+203
+135% +$28.9K ﹤0.01% 1779
2025
Q4
$25K Buy
150
+5
+3% +$836 ﹤0.01% 1920
2025
Q3
$28.4K Buy
+145
New +$23.8K ﹤0.01% 1837
2025
Q2
Sell
-25
Closed -$1.49K 2687
2025
Q1
$1.49K Hold
25
﹤0.01% 2553
2024
Q4
$3.31K Hold
25
﹤0.01% 2405
2024
Q3
$1.31K Buy
25
+17
+213% +$798 ﹤0.01% 2554
2024
Q2
$485 Buy
+8
New +$555 ﹤0.01% 2627

Other funds holding ALAB

Quadrant Capital Group's ALAB Position: Q2 2026 in Review

Quadrant Capital Group sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 353 shares — an estimated $38.7K sold.

Quadrant Capital Group first reported a position in ALAB in Q2 2024 and held it in 7 quarters. The position peaked at $38.7K in Q1 2026. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Quadrant Capital Group reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 353 Astera Labs shares in Q2 2026, an estimated $38.7K.
  • Quadrant Capital Group first reported a position in Astera Labs in Q2 2024 and held it in 7 quarters.
  • Quadrant Capital Group's Astera Labs position peaked at $38.7K in Q1 2026.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.